Medical Condition News

RSS

Regenstrief research scientist voted president-elect of the American Delirium Society

Regenstrief Research Scientist Noll Campbell, PharmD, M.S., has been voted president-elect of the American Delirium Society (ADS) by the board of directors. Dr. Campbell will be installed into office in conjunction with the society's national conference in June of 2023.

29 Aug 2022

Anonymous $5.75 million gift will enable UVA to fight against rare blood cancers

A gift of more than $5.75 million from anonymous donors will allow UVA Cancer Center to speed the development of new treatments for rare blood cancers and provide more patients with these cancers access to cutting-edge clinical trials.

29 Aug 2022

Researchers identify multiple genes and rare variants linked with Crohn's disease susceptibility

An international consortium of researchers has identified genetic variants in 10 genes that elevate a person's susceptibility to Crohn's disease, a form of inflammatory bowel disease.

29 Aug 2022

Music intervention can help bridge the gap between dementia patients and their loved ones

People with dementia often lose their ability to communicate verbally with loved ones in later stages of the disease.

29 Aug 2022

Implanted brain-stimulating device disrupts craving-related signals and reduces bingeing episodes

A small device that detects food craving-related brain activity in a key brain region, and responds by electrically stimulating that region, has shown promise in a pilot clinical trial in two patients with loss-of-control binge eating disorder (BED), according to researchers at the Perelman School of Medicine at the University of Pennsylvania.

29 Aug 2022

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

The immune system has evolved to safeguard the body from a wildly diverse range of potential threats. Among these are bacterial diseases, including plague, cholera, diphtheria and Lyme disease, and viral contagions such as influenza, Ebola virus and SARS CoV-2.

29 Aug 2022

Performing moderate or vigorous physical activity may lower the risk of heart failure

A six-year analysis of more than 94,000 adults in the U.K. Biobank with no history of heart failure at enrollment has found that engaging in moderate or vigorous physical activity may lower the risk of developing heart failure, according to new research published today in the American Heart Association's flagship journal Circulation.

29 Aug 2022

Combination of anemia and weak muscles increases the risk of death in older people

A study by researchers at the Federal University of São Carlos in Brazil and University College London in the United Kingdom shows that a combination of anemia and weak muscles in older people heightens the risk of death in ten years by 64% for men and by 117% for women.

29 Aug 2022

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Alzheimer's disease (AD) is the most common type of dementia affecting an estimated 6.3 million Americans age 65 and older. Without the development of medical breakthroughs to prevent, treat, slow or cure AD that number could grow to 13.8 million by 2060.

29 Aug 2022

Novel method for accurate diagnosis and treatment of uveitis

An estimated five to ten percent of blindness worldwide is caused by the rare inflammatory eye disease uveitis. Posterior uveitis in particular is often associated with severe disease progression and the need for immunosuppressive therapy.

29 Aug 2022

People with autoimmune disorder have a higher risk of developing cardiovascular disease

Around ten percent of the population in high income regions like Europe and the United States has been diagnosed with one or multiple autoimmune disorders.

29 Aug 2022

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

A large-scale international study led by Mount Sinai has yielded the first risk score that can help predict mortality for patients with atrial fibrillation (AFib) who have undergone a successful transcatheter aortic valve replacement (TAVR) and discharged home.

29 Aug 2022

Study shows SARS-CoV-2 infection provides strong protection from reinfection

Researchers assess the durability and effectiveness of immune responses against SARS-CoV-2 in terms of spike-binding antibody titers.

29 Aug 2022

$Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction$

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

Dapagliflozin reduces the risks of death and cardiovascular events in patients with heart failure regardless of ejection fraction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

$SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction$

SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction

An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and empagliflozin reduce cardiovascular death or hospitalization for heart failure by 20% in heart failure patients with mildly reduced and preserved ejection fraction.

28 Aug 2022

Increased incidence of hypertensive disorders of pregnancy in young Americans

An age-period-cohort analysis investigates the relationship between the age, birth year, and year of delivery with new onset of hypertensive disorders.

28 Aug 2022

Tattoos can induce bloodstream infections

A recent review describes the characteristics of systemic bacterial infections associated with tattoos.

28 Aug 2022

Trial shows superiority of AI in assessing cardiac function to sonographer assessment

In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by artificial intelligence (AI) is superior to initial sonographer assessment, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischaemic heart disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Medical Condition News

Regenstrief research scientist voted president-elect of the American Delirium Society

Anonymous $5.75 million gift will enable UVA to fight against rare blood cancers

Researchers identify multiple genes and rare variants linked with Crohn's disease susceptibility

Music intervention can help bridge the gap between dementia patients and their loved ones

Implanted brain-stimulating device disrupts craving-related signals and reduces bingeing episodes

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

Performing moderate or vigorous physical activity may lower the risk of heart failure

Combination of anemia and weak muscles increases the risk of death in older people

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Novel method for accurate diagnosis and treatment of uveitis

People with autoimmune disorder have a higher risk of developing cardiovascular disease

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

Study shows SARS-CoV-2 infection provides strong protection from reinfection

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction

Increased incidence of hypertensive disorders of pregnancy in young Americans

Tattoos can induce bloodstream infections

Trial shows superiority of AI in assessing cardiac function to sonographer assessment

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News